Polycystic ovarian syndrome-current pharmacotherapy and clinical implications

Rumaisa Rashid, Suhail Ahmad Mir, Ozaifa Kareem, Tabassum F. Ali, Rifat Ara, Anjum Malik, Fiza Amin, Ghulam Nabi Bader
ISSN / E-ISSN
— / —
DOI
10.1016/j.tjog.2021.11.009 ↗
Volume · Issue · Pages
61 · 1 · 40-50
Publisher
Elsevier Taiwan LLC
Article URL
https://doi.org/10.1016/j.tjog.2021.11.009 ↗
Article details
Unverified
Publication date (each date has its type and source)
01 Jan 2022
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date01 Jan 2022 OpenAlex

Keywords (as given): polycystic ovary syndrome; pharmacotherapy; metformin; oral contraceptives; androgen receptor antagonists; insulin sensitizers; myo-inositol; GLP-1 receptor agonists; DPP-4 inhibitors; SGLT2 inhibitors; vitamin D; statins; letrozole; hirsutism; electrolysis; laser hair removal; difluoromethylornithine; acupuncture; herbal medicine

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized X
Based on the recorded HEC dataset applicable to the article's publication date. Listed as X in the HEC list for hjrs 2021-22 V2.
Journal
Taiwanese Journal of Obstetrics and Gynecology
Publication date used
01 Jan 2022 (OpenAlex publication date)
Applicable HEC period
hjrs 2021-22 V2 (version 1) · 01 Jul 2021 – 30 Jun 2022
Category
X
Recognition status
Recognized (OK_RECORD_FOUND)
Source
hjrs-2021-22 row 16977
Verification status
Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.